Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y. Cossart (2004)
Human Parvovirus B19American Journal of Transplantation, 4
L. Harel, R. Straussberg, H. Rudich, A. Cohen, J. Amir (2000)
Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 30 3
M. Söderlund, R. Essen, J. Haapasaari, U. Kiistala, O. Kiviluoto, K. Hedman (1997)
Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathyThe Lancet, 349
ED Heegaard (2002)
485Clin Microbiol Rev, 15
JR Kerr (2006)
385
S. Dorsch, G. Liebisch, B. Kaufmann, P. Landenberg, J. Hoffmann, W. Drobnik, S. Modrow (2002)
The VP1 Unique Region of Parvovirus B19 and Its Constituent Phospholipase A2-Like ActivityJournal of Virology, 76
H. Lehmann, A. Knöll, R. Küster, S. Modrow (2003)
Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.Arthritis and rheumatism, 48 6
F. Oğuz, C. Akdeniz, E. Ünüvar, Ö. Küçükbasmacı, M. Sidal (2002)
Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritisJournal of Paediatrics and Child Health, 38
P. Cassinotti, G. Siegl (2000)
Quantitative Evidence for Persistence of Human Parvovirus B19 DNA in an Immunocompetent IndividualEuropean Journal of Clinical Microbiology and Infectious Diseases, 19
H. Lehmann, L. Kühner, K. Beckenlehner, E. Müller-Godeffroy, K. Heide, R. Küster, S. Modrow (2002)
Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 25 2
J. Nocton, L. Miller, L. Tucker, J. Schaller (1993)
Human parvovirus B19-associated arthritis in children.The Journal of pediatrics, 122 2
S. Oliveira, L. Camacho, Antonio Pereira, T. Faillace, S. Setúbal, J. Nascimento (2002)
Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil).Memorias do Instituto Oswaldo Cruz, 97 7
P. Landenberg, H. Lehmann, A. Knöll, S. Dorsch, S. Modrow (2003)
Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.Arthritis and rheumatism, 48 7
L. Liefeldt, A. Plentz, B. Klempa, O. Kershaw, A. Endres, U. Raab, H. Neumayer, H. Meisel, S. Modrow (2005)
Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real‐time PCR for simultaneous detection of genotypes 1 to 3Journal of Medical Virology, 75
P. Norja, K. Hokynar, L. Aaltonen, Renwei Chen, A. Ranki, E. Partio, O. Kiviluoto, I. Davidkin, T. Leivo, A. Eis-Hübinger, B. Schneider, H. Fischer, R. Tolba, O. Vapalahti, A. Vaheri, M. Söderlund-Venermo, K. Hedman (2006)
Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue.Proceedings of the National Academy of Sciences of the United States of America, 103 19
J. Kerr, S. Modrow (2005)
Human and primate erythrovirus infections and associated disease
SA Oliveira, LA Camacho, AC Pereira, TF Faillace, S Setubal, JP Nascimento (2002)
Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in BrazilMem Inst Oswaldo Crus, 97
JJ Nocton (1993)
186J Pediat, 122
Children with rheumatic oligo- and polyarthritis frequently establish persistent parvovirus B19 infections, which may be associated with the production of antiphospholipid antibodies. Reported in this paper are the data of five girls with polyarticular rheumatic diseases of different types and persistent parvovirus B19 infection associated in four cases with the presence of antibodies against phospholipids. Clinical parameters, virus load, and antiphospholipid-IgG levels were determined during an observation period up to 92 months. In two patients, erythema infectiosum preceded the development of arthritis and B19 viremia persisted. Two other girls showed antibodies against parvoviral structural proteins at time of the manifestation of the rheumatic disease. Subsequent samples also revealed persistent B19 infection. In the fifth patient, parvovirus B19-specific IgG antibodies were detected for the first time after 120 months of progressing disease at an age of 11 1/2 years. Five years later, quantitative polymerase chain reaction (PCR) revealed viral DNA. In a synovial tissue specimen subsequently obtained, parvovirus B19 structural proteins could be detected by immunohistochemistry. Three of five patients recovered completely without severe sequels. One patient is in remission under immunosuppressive therapy. The fifth patient suffers from progressive erosions despite intensive therapeutical efforts. In consequence, parvovirus B 19 should generally be taken into consideration as a trigger of various forms of juvenile arthritis and persistence of infection should be evaluated.
Clinical Rheumatology – Springer Journals
Published: Mar 1, 2008
Keywords: Antiphospholipid antibodies; Juvenile arthritis; Parvovirus B19; Persistent infection
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.